EUVIMEDEUVIMED entdecken
Klinische Studie

Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma

Lars H Nordenmark, Åsa Hellqvist, Claire Emson, Sarah Diver, Celeste Porsbjerg, Janet M Griffiths, John D Newell, Samuel Peterson, Beata Pawlikowska, Jane R Parnes, Ayman Megally, Gene Colice und 1 weitere

NEJM Evidence · 26.09.2023 · 2 (10)

DOI: 10.1056/evidoa2300135 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift NEJM Evidence, erschienen am 26.09.2023. Verfasst von Lars H Nordenmark und 12 weiteren Autor:innen. Beteiligte Einrichtung: Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Oslo. Hauptthemen laut MEDLINE: Airway Obstruction, Asthma. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Airway ObstructionAsthmaHumansAntibodies, Monoclonal, HumanizedMucus

Substanzen

Antibodies, Monoclonal, Humanizedtezepelumab

Autor:innen und Institutionen

  • Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Oslo.
  • Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.
  • National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
  • Department of Respiratory Medicine, Bispebjerg University Hospital, University of Copenhagen, Copenhagen.
  • Department of Radiology and Biomedical Engineering, University of Iowa, Iowa City.

Zitieren

APA

Nordenmark, L. H., Hellqvist, Å., Emson, C., Diver, S., Porsbjerg, C., Griffiths, J. M., Newell, J. D., Peterson, S., Pawlikowska, B., Parnes, J. R., Megally, A., Colice, G., & Brightling, C. E. (2023). Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma. NEJM Evidence, 2(10). https://doi.org/10.1056/evidoa2300135

Vancouver

Nordenmark LH, Hellqvist Å, Emson C, Diver S, Porsbjerg C, Griffiths JM, et al. Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma. NEJM Evidence. 2023;2(10). doi:10.1056/evidoa2300135

BibTeX
@article{Nordenmark2023,
  author = {Nordenmark, Lars H and Hellqvist, Åsa and Emson, Claire and Diver, Sarah and Porsbjerg, Celeste and Griffiths, Janet M and Newell, John D and Peterson, Samuel and Pawlikowska, Beata and Parnes, Jane R and Megally, Ayman and Colice, Gene and Brightling, Christopher E},
  title = {Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma},
  journal = {NEJM Evidence},
  year = {2023},
  volume = {2},
  number = {10},
  doi = {10.1056/evidoa2300135}
}
Kostenlos starten →